Viewing Study NCT06465433


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-01-05 @ 9:39 PM
Study NCT ID: NCT06465433
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2024-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module